Device / Technology News

RSS

Carrot Medical, MAVIG execute global marketing and sales channel partnership agreement

Carrot Medical, a leading designer of integrated medical imaging display systems, and MAVIG GmbH, the leading manufacturer of medical imaging monitor suspension systems, announced today the execution of a global marketing and sales channel partnership agreement. This partnership provides a semi-exclusive contract for the sale of all products through MAVIG's global sales channel while offering MAVIG access to the next generation of integrated medical imaging display technology.

12 May 2010

Clinical Data expands PGxHealth's FAMILION tests to include two new tests to diagnose heart diseases

Clinical Data, Inc., announced today that its PGxHealth division is expanding its FAMILION family of genetic tests to include two new tests to diagnose heart diseases. With the launch of a test for Conduction Disease associated with Dilated Cardiomyopathy and a test for Short QT Syndrome, PGxHealth continues to lead the industry with the most comprehensive menu of genetic tests to diagnose or confirm familial heart diseases.

12 May 2010

RevMed partners with Santa Monica to set up safety syringe manufacturing facility in Brazil

Revolutions Medical Corporation, has signed an agreement of understanding for the setting up of a manufacturing facility in Brazil to produce the RevVac safety syringe for domestic and global markets and to facilitate distribution throughout South America.

12 May 2010

Spectranetics to demonstrate new Laser Lead Extraction Simulation system at Heart Rhythm 2010

Spectranetics Corporation today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society's (HRS) 31st Annual Scientific Sessions, Heart Rhythm 2010. The new simulation system is intended to augment traditional procedural training for physicians on laser-assisted lead extraction procedures by permitting hands-on practice with extraction tools and techniques in multiple case scenarios in a virtual operating environment.

12 May 2010

TSO3 first-quarter net loss increases to $2,033,932

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, posted revenues of $144,228 for the sales of consumables and services for its first generation STERIZONE(R) Sterilizer (125L) for the first quarter ended March 31, 2010. This compares with $533,488 for the same period in the prior year in which three sterilizers (125L), consumables and services were sold.

12 May 2010

Drug-releasing stents do not result in fewer deaths or subsequent heart attacks after angioplasty

Drug-releasing stents are more effective than bare metal stents at keeping a blocked artery open after angioplasty, but the difference does not result in fewer deaths or subsequent heart attacks after the procedure, according to a review of recent studies.

12 May 2010

Regenstrief Institute framework evaluates costs, effort and value of health internet

As the United States moves toward the goal of a secure nationwide health information network, a new study from the Regenstrief Institute provides a framework for evaluating the costs, effort and value of what is sometimes referred to as the health internet.

12 May 2010

Kallisto demonstrates major new version of BYOSYS solution at Orthopädie + Reha-Technik show

SensAble Technologies, Inc®, a leading provider of 3D modeling solutions and haptic devices, announced that its customer, Kallisto, a provider of 3D technologies as well as rapid prototyping and manufacturing solutions to the orthotics and prosthetics industry, is showcasing a major new version of its BYOSYS® solution at Europe's leading industry event, the Orthopädie + Reha-Technik show, which opened in Leipzig, Germany today.

12 May 2010

BioGenes study documents insufficient sensitivity of ELISA-based generic HCP assay

BioGenes GmbH, a supplier of GMP-compliant immunoassays and antibodies, completed a study that documents the insufficient sensitivity of an ELISA-based generic host cell protein assay. The results confirm the observation of several contract manufacturers that generic HCP assays are only of limited use for detection of HCPs during manufacturing processes.

12 May 2010

Gamma Knife stereotactic radiosurgery safe for treating children with arteriovenous malformations: Study

A new Mayo Clinic study has found that Gamma Knife™ stereotactic radiosurgery is a safe and effective option for selected children with arteriovenous malformations. This study was presented at the American Association of Neurological Surgeons Annual Meeting in Philadelphia last week.

12 May 2010

3M Healthcare Data Dictionary to be integrated with CitiusTech's BI-Clinical business intelligence framework

CitiusTech, a leading provider of healthcare technology solutions and services, has signed an agreement with 3M Health Information Systems to integrate the 3M(TM) Healthcare Data Dictionary with CitiusTech's BI-Clinical healthcare business intelligence framework. The agreement will enable BI-Clinical clients to leverage the robust capabilities of the 3M Healthcare Data Dictionary for enhanced terminology mapping across source systems.

12 May 2010

Biotage extends peptide synthesis research collaboration with University of Copenhagen

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced an agreement to extend the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen, to develop new applications on the Biotage Syro Wave in the field of synthetic peptide and protein chemistry. The collaboration builds on Professor Jensen's previous research in developing novel chemistries for and applications of solid-phase peptide synthesis.

12 May 2010

Response Genetics, GSK sign non-exclusive license agreement for BRAF mutational analysis technology

Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced it has signed a non-exclusive license agreement with GlaxoSmithKline ("GSK"). Under the terms of the agreement, GSK gains certain rights to Response Genetics' proprietary PCR analysis technology and diagnostic expertise to assess BRAF gene mutations in human tumor samples. Payments will be made to Response Genetics upon achivement of agreed-to milestones.

12 May 2010

meridianEMR launches UROAnalytics tool

meridianEMR, Inc., a leading provider of electronic health records systems and advanced healthcare analytics for urology and surgical practices, today has announced the launch of its exclusive multi-dimensional clinical analysis tool – UROAnalytics.

12 May 2010

Optivia Biotechnology launches OptiDDI Suite for assessing transporter-related DDIs

Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced the launch of the OptiDDITM Suite, a novel assay panel that assesses the most clinically significant transporter-related drug-drug interactions (DDIs), as identified by the International Transporter Consortium (ITC) in its report "Membrane Transporters in Drug Development" (Nature Reviews-Drug Discovery, March 2010).

12 May 2010

New computer-based tool developed to benefit cancer patients

Cancer patients and doctors are finally getting on the same page about cancer survivorship, thanks to a free new tool that can benefit anyone who has been diagnosed with cancer.

12 May 2010

Stereotaxis launches Vdrive module for remote manipulation of diagnostic devices during EP procedures

Stereotaxis, Inc. today announces the introduction of its new Vdrive™, an expansion of its Magnetic Navigation platform that facilitates remote manipulation of diagnostic devices used during electrophysiology (EP) procedures. The company is planning to preview the Vdrive at the HRS meeting this week, and will be commercially available when regulatory processes are complete.

12 May 2010

Researchers develop new method for tracing carbon flux

Microbial communities are performing important functions all around us - from the earth in our flowerpots to the human gut. Now researchers have developed a method for studying the metabolic functions of microbial communities in detail.

12 May 2010

Neurimmune Therapeutics honored with ZKB TECHNOPARK Pioneer Award

The ZKB TECHNOPARK® Pioneer Award, which has been sponsored by the Zürcher Kantonalbank since 2000, was presented for the 20th time at TECHNOPARK® Zurich. The award is given for technological innovations which - thanks to pioneering entrepreneurial achievements - are about to be launched on the market. This year's award winner is Neurimmune Therapeutics AG, represented by Dr. Jan Grimm, Professor Christoph Hock, Professor Roger Nitsch and Dr. Michael Salzmann.

12 May 2010

Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device

St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) of its AnalyST™ implantable cardioverter defibrillator (ICD) with ST Monitoring, a revolutionary device that not only provides life-saving therapy for dangerously fast heart rhythms, but also continuously monitors electrical changes (called ST segments) to help physicians monitor for cardiac problems.

12 May 2010

Device / Technology News

Carrot Medical, MAVIG execute global marketing and sales channel partnership agreement

Clinical Data expands PGxHealth's FAMILION tests to include two new tests to diagnose heart diseases

RevMed partners with Santa Monica to set up safety syringe manufacturing facility in Brazil

Spectranetics to demonstrate new Laser Lead Extraction Simulation system at Heart Rhythm 2010

TSO3 first-quarter net loss increases to $2,033,932

Drug-releasing stents do not result in fewer deaths or subsequent heart attacks after angioplasty

Regenstrief Institute framework evaluates costs, effort and value of health internet

Kallisto demonstrates major new version of BYOSYS solution at Orthopädie + Reha-Technik show

BioGenes study documents insufficient sensitivity of ELISA-based generic HCP assay

Gamma Knife stereotactic radiosurgery safe for treating children with arteriovenous malformations: Study

3M Healthcare Data Dictionary to be integrated with CitiusTech's BI-Clinical business intelligence framework

Biotage extends peptide synthesis research collaboration with University of Copenhagen

Response Genetics, GSK sign non-exclusive license agreement for BRAF mutational analysis technology

meridianEMR launches UROAnalytics tool

Optivia Biotechnology launches OptiDDI Suite for assessing transporter-related DDIs

New computer-based tool developed to benefit cancer patients

Stereotaxis launches Vdrive module for remote manipulation of diagnostic devices during EP procedures

Researchers develop new method for tracing carbon flux

Neurimmune Therapeutics honored with ZKB TECHNOPARK Pioneer Award

Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News